Skip to main content
BNGO
NASDAQ Industrial Applications And Services

Bionano Q2 revenue climbs 21%, but going concern warning persists as cash dwindles to $3.7M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.17
Mkt Cap
$13.311M
52W Low
$1
52W High
$5.5
52W Position info
17% above low
Off High info
79% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

BNGO sits 17% above its 52-week low of $1.

Summary

Bionano's Q2 revenue grew 21% to $8.2M, but cash fell to $3.7M and the going concern warning was reiterated. The company must raise capital urgently to avoid bankruptcy.


Key Events · Earnings and Guidance · BNGO

  • Q2 Revenue Up 21%

    Total revenue reached $8.2 million, driven by a 31% increase in consumables sales and a 46% jump in instrument revenue.

  • Going Concern Warning Reiterated

    Management expressed substantial doubt about the company's ability to continue as a going concern within 12 months, citing recurring losses and negative cash flows.

  • Cash Position Deteriorates

    Cash and equivalents fell to $3.7 million as of June 30, 2026, after burning $10.4 million in operating cash during the first half.

  • Convertible Debentures Fully Redeemed

    The remaining $10.3 million principal balance of the JGB debentures was repaid in full, eliminating the debt but further straining liquidity.


Analysis · BNGO · Industrial Applications And Services

A solid 21% revenue increase to $8.2 million in Q2 was driven by a 31% jump in consumables. Yet the company burned $10.4 million in cash from operations over the first half, leaving just $3.7 million in cash and equivalents. Management reiterated substantial doubt about its ability to continue as a going concern within 12 months, stating it must raise capital in the very near term or face potential bankruptcy. The full repayment of $10.3 million in convertible debentures removed a debt overhang but drained liquidity. Against this backdrop, the board appointed interim CEO Albert Luderer and retained former CEO Erik Holmlin as a consultant, signaling a leadership transition amid the crisis.

At the time of this filing, BNGO was trading at $1.17 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $13.3M. The 52-week trading range was $1.00 to $5.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BNGO - Latest Insights

BNGO
Aug 10, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.15 info
Change: -$0.0152 (-1%) info
Market Cap: $13.311M info
BNGO
Jun 24, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.15
Real-time Price: $1.15 info
Change: +$0.0043 (+0.37%) info
Market Cap: $13.311M info
BNGO
Jun 18, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.17
Real-time Price: $1.15 info
Change: -$0.0145 (-1%) info
Market Cap: $13.311M info
BNGO
Jun 05, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.15 info
Change: -$0.0157 (-1%) info
Market Cap: $13.311M info
BNGO
Jun 05, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.15 info
Change: -$0.0157 (-1%) info
Market Cap: $13.311M info